Compare Personalis Inc. Common Stock (PSNL) vs Vanguard Dividend Appreciation Index Fund ETF (VIG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Personalis Inc. Common Stock vs Vanguard Dividend Appreciation Index Fund ETF — how do they compare? Personalis Inc. Common Stock trades at $16.07 (market cap $1.69B), while Vanguard Dividend Appreciation Index Fund ETF trades at $239.98 (market cap $132.40B). The key difference: Vanguard Dividend Appreciation Index Fund ETF is far larger — about 78.3× Personalis Inc. Common Stock's market cap, and Personalis Inc. Common Stock is more actively traded (3,817,236 versus 1,027,126). Which is the better fit depends on your goals — on Pluang, investors hold Personalis Inc. Common Stock for 0 Days and Vanguard Dividend Appreciation Index Fund ETF for 134 Days on average.
| PSNL | VIG | |
|---|---|---|
Market Cap | $1.69B | $132.40B |
Volume | 3,817,236 | 1,027,126 |
Sector | Health | — |
52-Week High | $18.38 | $246.61 |
52-Week Low | $5.04 | $210.70 |
Typical Hold Time | 0 Days | 134 Days |
Enterprise Value | $1.52B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
VIG trades at $239.98, showing minimal daily movement with a slight decline of 0.02%. The technical outlook is bullish based on moving averages, though oscillators are neutral. Recent news highlights its focus on dividend growth, with a 7.5% quarterly dividend increase noted by Seeking Alpha on September 27, 2026. The ETF's strategy excludes high-yield stocks to prioritize consistent dividend growers, as reported by The Motley Fool on September 26, 2026.
The outlook for VIG is supported by its historical average annual returns of 10%, but risks include slow dividend growth and competition from higher-yield ETFs. Investor sentiment is mixed, with some analysts favoring its growth profile over immediate income. Key risks involve market volatility and the ETF's strict eligibility criteria limiting yield potential.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Personalis Inc. Common Stock
Personalis Inc. is a cancer genomics company that provides tumor- and blood-based DNA and RNA sequencing tests, including its NeXT Personal liquid biopsy test for cancer monitoring.
Read more on PSNL →About Vanguard Dividend Appreciation Index Fund ETF
The advisor employs an indexing investment approach designed to track the performance of the index, which consists of common stocks of companies that have a record of increasing dividends over time. The advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.
Read more on VIG →
